This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Fluoxetine-Induced Sexual Dysfunction Reversed by Loratadine

Russel V. Brubaker

Published: June 18, 2002

Article Abstract

Letter to the Editor

Sir: Sexual dysfunction as a side effect of antidepressant treatment occurs at a rate of roughly 50% of treated patients. Fluoxetine is no exception. Attempts at reversing sexual side effects in selective serotonin reuptake inhibitors (SSRIs) have included dosage reduction, change to a different SSRI or non- SSRI, and adding bupropion, Ginkgo biloba, cyproheptadine, yohimbine, trazodone, and sildenafil, all with varying degrees of success. In this study, loratadine, a long-acting tricyclic antihistamine with selective peripheral histamine H1 receptor antagonistic activity, appeared to be very helpful in reversing fluoxetine-induced sexual dysfunction.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 63

Quick Links: Depression (MDD) , Sexual Dysfunction

References